Indian Pharma’s Day of Reckoning

The pharmaceutical industry is often thought of as tired and old because of its risk-averse nature. Hardly anything exciting or ‘game-changing’ happens in it. However, it appears that around the bend lies a stormy time that will test the mettle of its leaders. Over the last few days at least three very important developments took […]

Read More Indian Pharma’s Day of Reckoning